Cargando…

Association of plasma levels of Protein S with disease severity in multiple sclerosis

BACKGROUND: The TAM family of receptor tyrosine kinases (TYRO3, AXL and MERTK) play important roles in modulating innate immune responses and central demyelination. The TAM receptor ligand Protein S (PROS) has also been shown to modulate innate immune cell responses. OBJECTIVES: We assessed whether...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Gerry ZM, Giuffrida, Lauren L, Gresle, Melissa M, Haartsen, Jodi, Laverick, Louise, Butzkueven, Helmut, Field, Judith, Binder, Michele D, Kilpatrick, Trevor J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433335/
https://www.ncbi.nlm.nih.gov/pubmed/28607700
http://dx.doi.org/10.1177/2055217315596532
_version_ 1783236832321863680
author Ma, Gerry ZM
Giuffrida, Lauren L
Gresle, Melissa M
Haartsen, Jodi
Laverick, Louise
Butzkueven, Helmut
Field, Judith
Binder, Michele D
Kilpatrick, Trevor J
author_facet Ma, Gerry ZM
Giuffrida, Lauren L
Gresle, Melissa M
Haartsen, Jodi
Laverick, Louise
Butzkueven, Helmut
Field, Judith
Binder, Michele D
Kilpatrick, Trevor J
author_sort Ma, Gerry ZM
collection PubMed
description BACKGROUND: The TAM family of receptor tyrosine kinases (TYRO3, AXL and MERTK) play important roles in modulating innate immune responses and central demyelination. The TAM receptor ligand Protein S (PROS) has also been shown to modulate innate immune cell responses. OBJECTIVES: We assessed whether plasma levels of PROS are changed in multiple sclerosis (MS) patients and whether changes are associated with disease severity. METHODS: Plasma levels of total and free PROS were measured using enzyme-linked immunosorbent assay in a discovery cohort (MS: 65, control: 14) and an independent replication cohort (MS: 29, control: 29). The Multiple Sclerosis Severity Score (MSSS) was used to evaluate associations between plasma PROS levels and disease severity. RESULTS: We found plasma levels of total, but not free PROS, were decreased in MS patients compared with controls. In female MS patients, we observed decreases in total and free PROS levels compared with controls. In addition, we also observed higher MSSS in patients with very low levels of plasma free PROS. CONCLUSIONS: These data suggest PROS may represent a potential marker of disease severity in MS.
format Online
Article
Text
id pubmed-5433335
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-54333352017-06-12 Association of plasma levels of Protein S with disease severity in multiple sclerosis Ma, Gerry ZM Giuffrida, Lauren L Gresle, Melissa M Haartsen, Jodi Laverick, Louise Butzkueven, Helmut Field, Judith Binder, Michele D Kilpatrick, Trevor J Mult Scler J Exp Transl Clin Original Article BACKGROUND: The TAM family of receptor tyrosine kinases (TYRO3, AXL and MERTK) play important roles in modulating innate immune responses and central demyelination. The TAM receptor ligand Protein S (PROS) has also been shown to modulate innate immune cell responses. OBJECTIVES: We assessed whether plasma levels of PROS are changed in multiple sclerosis (MS) patients and whether changes are associated with disease severity. METHODS: Plasma levels of total and free PROS were measured using enzyme-linked immunosorbent assay in a discovery cohort (MS: 65, control: 14) and an independent replication cohort (MS: 29, control: 29). The Multiple Sclerosis Severity Score (MSSS) was used to evaluate associations between plasma PROS levels and disease severity. RESULTS: We found plasma levels of total, but not free PROS, were decreased in MS patients compared with controls. In female MS patients, we observed decreases in total and free PROS levels compared with controls. In addition, we also observed higher MSSS in patients with very low levels of plasma free PROS. CONCLUSIONS: These data suggest PROS may represent a potential marker of disease severity in MS. SAGE Publications 2015-07-24 /pmc/articles/PMC5433335/ /pubmed/28607700 http://dx.doi.org/10.1177/2055217315596532 Text en © The Author(s) 2015 http://creativecommons.org/licenses/by-nc/3.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page(https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Article
Ma, Gerry ZM
Giuffrida, Lauren L
Gresle, Melissa M
Haartsen, Jodi
Laverick, Louise
Butzkueven, Helmut
Field, Judith
Binder, Michele D
Kilpatrick, Trevor J
Association of plasma levels of Protein S with disease severity in multiple sclerosis
title Association of plasma levels of Protein S with disease severity in multiple sclerosis
title_full Association of plasma levels of Protein S with disease severity in multiple sclerosis
title_fullStr Association of plasma levels of Protein S with disease severity in multiple sclerosis
title_full_unstemmed Association of plasma levels of Protein S with disease severity in multiple sclerosis
title_short Association of plasma levels of Protein S with disease severity in multiple sclerosis
title_sort association of plasma levels of protein s with disease severity in multiple sclerosis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433335/
https://www.ncbi.nlm.nih.gov/pubmed/28607700
http://dx.doi.org/10.1177/2055217315596532
work_keys_str_mv AT magerryzm associationofplasmalevelsofproteinswithdiseaseseverityinmultiplesclerosis
AT giuffridalaurenl associationofplasmalevelsofproteinswithdiseaseseverityinmultiplesclerosis
AT greslemelissam associationofplasmalevelsofproteinswithdiseaseseverityinmultiplesclerosis
AT haartsenjodi associationofplasmalevelsofproteinswithdiseaseseverityinmultiplesclerosis
AT lavericklouise associationofplasmalevelsofproteinswithdiseaseseverityinmultiplesclerosis
AT butzkuevenhelmut associationofplasmalevelsofproteinswithdiseaseseverityinmultiplesclerosis
AT fieldjudith associationofplasmalevelsofproteinswithdiseaseseverityinmultiplesclerosis
AT bindermicheled associationofplasmalevelsofproteinswithdiseaseseverityinmultiplesclerosis
AT kilpatricktrevorj associationofplasmalevelsofproteinswithdiseaseseverityinmultiplesclerosis